Patrick Vallance answering questions at Downing Street press briefing

The video discusses the ongoing progress in vaccine rollout and the development of new medicines, including antiviral drugs. It emphasizes the importance of monitoring and assessing the situation without focusing on specific dates. The risks associated with delaying the second vaccine dose and the potential for mutations are addressed. The video also explains how virus mutations occur naturally during replication and the role of partial immunity in controlling infections.

What is the relationship between vaccine pressure and the mutations observed in the virus?

What benefits can partial immunity provide in the context of virus transmission?